CKD Bio Corp. (KRX:063160)
South Korea
· Delayed Price · Currency is KRW 22,800
-200 (-0.87%)
At close: Aug 14, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY undefined | FY undefined | FY undefined | FY undefined | FY undefined | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
| Drug Substance | 142.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Substance Growth | 6.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Probiotics | 24.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Probiotics Growth | 26.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Botulinum Toxin | 4.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Botulinum Toxin Growth | -35.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Ingredients and Health Functional Foods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Ingredients and Health Functional Foods Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY undefined | FY undefined | FY undefined | FY undefined | FY undefined | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
| Other | 24.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 49.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 51.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 38.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 48.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -13.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 35.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -4.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East | 11.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East Growth | -13.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 24.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 49.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|